Azenta, Inc. (LON:0HQ1)

London flag London · Delayed Price · Currency is GBP · Price in USD
28.16
-1.00 (-3.43%)
Feb 12, 2026, 4:53 PM GMT
Market Cap1.03B -48.4%
Revenue (ttm)442.11M +2.7%
Net Income-44.73M
EPS-0.98
Shares Outn/a
PE Ration/a
Forward PE33.04
Dividendn/a
Ex-Dividend Daten/a
Volume36
Average Volume155
Open30.39
Previous Close29.16
Day's Range28.16 - 30.39
52-Week Range25.12 - 47.18
Beta1.34
RSI38.95
Earnings DateFeb 4, 2026

About Azenta

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sampl... [Read more]

Sector Healthcare
Founded 1978
Employees 3,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HQ1
Full Company Profile

Financial Performance

In fiscal year 2025, Azenta's revenue was $593.82 million, an increase of 3.55% compared to the previous year's $573.45 million. Losses were -$55.76 million, -66.18% less than in 2024.

Financial numbers in USD Financial Statements

News

Azenta (AZTA): Evercore ISI Group Lowers Price Target but Maintains Rating | AZTA Stock News

Azenta (AZTA): Evercore ISI Group Lowers Price Target but Maintains Rating | AZTA Stock News

7 days ago - GuruFocus

Jefferies Lowers Azenta (AZTA) Price Target, Maintains Buy Rating | AZTA Stock News

Jefferies Lowers Azenta (AZTA) Price Target, Maintains Buy Rating | AZTA Stock News

8 days ago - GuruFocus

Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript

Azenta, Inc. (AZTA) Q1 2026 Earnings Call February 4, 2026 8:30 AM ESTCompany ParticipantsYvonne Perron - Vice President of Financial Planning &...

8 days ago - Seeking Alpha

Q1 2026 Azenta Inc Earnings Call Transcript

Q1 2026 Azenta Inc Earnings Call Transcript

8 days ago - GuruFocus

Needham Reiterates "Buy" Rating for Azenta (AZTA) with $44 Price Target | AZTA Stock News

Needham Reiterates "Buy" Rating for Azenta (AZTA) with $44 Price Target | AZTA Stock News

8 days ago - GuruFocus

Azenta Stock Falls 22% Over Wider Loss EPS In Q1

(RTTNews) - Stock of Azenta, Inc. (AZTA) is dropping about 22 percent on Wednesday morning trading following the announcement of its first quarter financial results, reporting loss of $0.34 per share ...

8 days ago - Nasdaq

Azenta (AZTA) Q1 2026 Earnings Call Transcript

Azenta (AZTA) Q1 2026 Earnings Call Transcript

8 days ago - The Motley Fool

Azenta Earnings Review: Q1 Summary

Azenta (NASDAQ: AZTA) released its Q1 earnings on Wednesday, February 4, 2026 at 06:30 AM. Here's what's important from the earnings announcement. Earnings Azenta missed estimated earnings by -25.0%,...

8 days ago - Benzinga

Azenta: Q1 Earnings Insights

The earnings results for Azenta (NASDAQ: AZTA) for Q1 were made public on Wednesday, February 4, 2026 at 06:30 AM. Here's a comprehensive overview of the announcement. Earnings Azenta missed estimate...

8 days ago - Benzinga

Azenta Q1 Earnings Report: What Investors Need to Know

Azenta (NASDAQ: AZTA) announced its Q1 earnings on Wednesday, February 4, 2026 at 06:30 AM. Here's a breakdown of the earnings report. Earnings Azenta missed estimated earnings by -25.0%, reporting a...

8 days ago - Benzinga

Azenta reports mixed Q1 results; reaffirms FY26 outlook

Azenta press release (AZTA): Q1 Non-GAAP EPS of $0.09 misses by $0.04. Revenue of $149M (+1.4% Y/Y) beats by $1.9M. Organic revenue, which excludes the impact from foreign exchange,

8 days ago - Seeking Alpha

Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025

BURLINGTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025.

8 days ago - PRNewsWire

Azenta Q1 2026 Earnings Preview

9 days ago - Seeking Alpha

Azenta Inc Annual Shareholders Meeting Transcript

Azenta Inc Annual Shareholders Meeting Transcript

15 days ago - GuruFocus

Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast

BURLINGTON, Mass., Jan. 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2026 earnings which ended on December 31, 2025, on Wednesday, February 4, 2026, before t...

22 days ago - PRNewsWire

Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News

Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News

5 weeks ago - GuruFocus

New Strong Sell Stocks for January 8th

AZTA, BCBP and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on January 8th, 2026.

5 weeks ago - Nasdaq

AZTA: Evercore ISI Group Upgrades Rating and Raises Price Target | AZTA Stock News

AZTA: Evercore ISI Group Upgrades Rating and Raises Price Target | AZTA Stock News

5 weeks ago - GuruFocus

Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day

Vale stands out as Bull of the Day after a strong turnaround, rising production and a nearly 7% dividend push shares to new highs.

6 weeks ago - Nasdaq

Bear of the Day: Azenta (AZTA)

2025 was another turbulent year for Azenta (AZTA) stock, which fell more than 30% as the medical solutions provider struggled with ongoing sales weakness.

6 weeks ago - Nasdaq

New Strong Sell Stocks for December 30th

ASBFY, AZTA and ALG have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2025.

6 weeks ago - Nasdaq

Azenta's Subsidiary To Sell B Medical Systems Business To THELEMA For $63 Mln

(RTTNews) - Azenta, Inc. (AZTA), Monday announced that its affiliate, Azenta Germany GmbH, has signed an agreement to sell its B Medical Systems business, a manufacturer and distributor of medical ref...

6 weeks ago - Nasdaq

Azenta (AZTA) to Divest B Medical Systems for $63 Million

Azenta (AZTA) to Divest B Medical Systems for $63 Million

6 weeks ago - GuruFocus

Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

BURLINGTON, Mass. , Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical...

6 weeks ago - PRNewsWire